EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Results of GC – MS Analyses of 40 Extracts of Diabetes Devices

GC-MS-Analysen von 40 Extrakten aus Diabetesgeräten

Emma M van Oers, Anton C de Groot iD, Patrick Verolme, Norbertus A Ipenburg iD, Thomas Rustemeyer iD

Contact Dermatitis · 2026-03 · 94 (3) · 234-244

DOI: 10.1111/cod.70052 ↗

Auf einen Blick

In 40 Extrakten aus 27 Diabetesgeräten wurden Stoffe gefunden, die bereits als Allergene bei Kontaktdermatitis durch Diabetesgeräte bekannt sind.

Fragestellung

Welche Chemikalien sind in Diabetesgeräten enthalten?

Methode

40 Acetonextrakte von 27 Geräten wurden mittels Gaschromatographie-Massenspektrometrie untersucht.

Ergebnisse

Alle 40 Extrakte enthielten eine oder mehrere Chemikalien, die zuvor als Allergene in Diabetesgeräten beschrieben wurden. 14 von 27 Geräten enthielten Acrylate, 8 Colophonium-Derivate und 9 1-Hydroxycyclohexyl-phenylketon.

Schlussfolgerung der Autor:innen

Alle untersuchten Produkte enthielten Chemikalien, die bereits als Sensibilisatoren in Diabetesgeräten bekannt sind.

Kernaussagen

  • Alle 40 Extrakte enthielten bekannte Allergene.
  • 14 von 27 Geräten enthielten Acrylate; 8 Colophonium-Derivate.
  • Die Daten können gezielte Epikutantests und die Beratung zu Alternativen unterstützen.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Contact Dermatitis, published online on 2025-11-28. Written by Emma M van Oers and 4 co-authors. Institution: Amsterdam University Medical Centers, Amsterdam, the Netherlands. Major MEDLINE topics: Dermatitis, Allergic Contact, Allergens, Insulin Infusion Systems. Cited 4 times so far (Crossref); 9 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Dutch Diabetes Research Foundation, Diabetes Fonds.

Auf einen BlickAstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Diagnostic patch testing in patients with suspected allergic Contact Dermatitis from glucose sensors, insulin pumps, and infusion sets is seriously hampered by a lack of information on the chemical composition of these diabetes devices.

Objectives

To identify the chemicals present in diabetes devices. Materials and Methods Forty acetone extracts of 27 devices (10 sensors, 3 patch pumps, 12 infusion sets and 2 single adhesives) were investigated by gas chromatography—mass spectrometry.

Results

Two hundred eighty four individual chemicals were identified. All 40 extracts contained one or more chemicals that were previously identified as allergens in diabetes devices causing allergic Contact Dermatitis. Fourteen of 27 devices (52%) contained one or more acrylates, 8 (30%) colophonium derivatives, all 27 (100%) one or two phenolic allergens (2,4‐di‐ tert ‐butylphenol, p ‐ tert‐ butylphenol, butylated hydroxytoluene), and 9 (33%) 1‐hydroxycyclohexyl phenyl ketone. None of the other chemicals were well‐known haptens, with the exception of bisphenol A, which was present in half of the extracts, in some cases in very high concentrations.

Conclusions

All products investigated contained chemicals already known to be sensitizers in diabetes devices. The data can help determine the relevance of positive patch tests, facilitate targeted patch testing with potential allergens and aid in advising safer alternatives for sensitized patients.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactAllergensInsulin Infusion SystemsGas Chromatography-Mass SpectrometryHumansPatch TestsBlood Glucose Self-MonitoringPhenolsAcrylatesAdhesives

Author keywords

GC–MSacrylatesallergenscolophoniumdiabetes devicesgas chromatography—mass spectrometryglucose sensorinsulin pumpisocyanatesphenolic chemicals

Substances

AllergensPhenolsAcrylatesAdhesives

Authors and institutions

  • Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • NEDLAB, Middelharnis, the Netherlands.

ORCID profiles: Anton C de Groot, Norbertus A Ipenburg, Thomas Rustemeyer

Funding

  • Dutch Diabetes Research Foundation
  • Diabetes Fonds

Cite

APA

van Oers, E. M., de Groot, A. C., Verolme, P., Ipenburg, N. A., & Rustemeyer, T. (2026). Results of GC – MS Analyses of 40 Extracts of Diabetes Devices. Contact Dermatitis, 94(3), 234-244. https://doi.org/10.1111/cod.70052

Vancouver

van Oers EM, de Groot AC, Verolme P, Ipenburg NA, Rustemeyer T. Results of GC – MS Analyses of 40 Extracts of Diabetes Devices. Contact Dermatitis. 2026;94(3):234-244. doi:10.1111/cod.70052

BibTeX
@article{vanOers2026,
  author = {van Oers, Emma M and de Groot, Anton C and Verolme, Patrick and Ipenburg, Norbertus A and Rustemeyer, Thomas},
  title = {Results of GC – MS Analyses of 40 Extracts of Diabetes Devices},
  journal = {Contact Dermatitis},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {234--244},
  doi = {10.1111/cod.70052}
}
Start for free →